Article
Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.
Nature communications - 9 Feb 2021
Jiang Xiao-Lin, Wang Guo-Lin, Zhao Xiang-Na, Yan Fei-Hu, Yao Lin, Kou Zeng-Qiang, Ji Sheng-Xiang, Zhang Xiao-Li, Li Cun-Bao, Duan Li-Jun, Li Yan, Zhang Yu-Wen, Duan Qing, Wang Tie-Cheng, Li En-Tao, Wei Xiao, Wang Qing-Yang, Wang Xue-Feng, Sun Wei-Yang, Gao Yu-Wei, Kang Dian-Min, Zhang Ji-Yan, Ma Mai-Juan
Abstract excerpt
The dynamics, duration, and nature of immunity produced during SARS-CoV-2 infection are still unclear. Here, we longitudinally measured virus-neutralising antibody, specific antibodies against the spike (S) protein, receptor-binding domain (RBD), and the nucleoprotein (N) of SARS-CoV-2, as well as T cell responses, in 25 SARS-CoV-2-infected patients up to 121 days post-symptom onset (PSO). All patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.